Table 1.
Mouse models and phenotypes in the Hh signaling pathway.
| Mutation | Onset Stage of Knockout | Hh Signaling | Phenotype | Lethality Stage | Primary Publication |
|---|---|---|---|---|---|
| Shh−/− | Global | Down | Cyclopia, probiscus-like facial features, abnormal organ formation, reduced body size | Perinatal | [51] |
| Shhlox/lox;NestinCre | E12.5 | Down | Decrease in MGE size, defective early oligodendrogenesis, fewer proliferating neural stem cells (NSCs) in postnatal SVZ and hippocampus | N/A | [72] |
| Shhlox/lox;Emx1Cre | E10.5 | Down | Smaller dorsal telencephalon, abnormal neuron position and NSC characteristics | N/A | [53] |
| Ptch−/− | Global | Up | Open and overgrown neural tube | E9-10.5 | [61] |
| Ptch+/− | Global | Up | Partially open neural tube, hindbrain defects, overgrown cerebellum, larger body size | N/A | [61] |
| Ptch1lox/lox;NestinCre | E12.5 | Up | Surface of neocortex is folded with varying thickness, distorted brain structures in neocortex, MGE, hippocampus, medial cortex | E15.5 | [62] |
| Smo−/− | Global | Down | Heart defect, cyclopia, loss of Left/Right symmetry | E9.5 | [70] |
| Smolox/lox;FoxG1Cre | E9 | Down | Dorsalization of neural tube, loss of interneurons and oligodendrocytes | Perinatal | [71] |
| Smolox/lox;Emx1Cre | E10.5 | Down | Smaller telencephalon, defects in neuronal migration, significant loss of oligodendrocytes | N/A | [53] |
| Smolox/lox;GFAPCre | E13.5 | Down | Small brain, fewer INPs, fewer bRGCs | N/A | [44] |
| SmoM2 (drive by GFAPCre) | E13.5 | Up | Folding of the cingulate cortex, higher number of bRGs and INPs | N/A | [44] |
| Sufu−/− | Global | Up | Open ventralized neural tube | E9.5 | [73] |
| Sufu−/+ | Global | Up | Normal growth, fertile, develop Gorlin-like features | N/A | [73] |
| Sufulox/lox;GFAPCre | E13.5 | Up | No obvious phenotype, survive into adulthood, expanded VZ and SVZ | N/A | [75] |
| Sufulox/lox;Emx1Cre | E10.5 | Up | Large cortical surface, no olfactory bulb, expanded lateral ventricles, thinner cortical layer | Death before weaning | [75] |
| Gli1−/− | Global | N/A | Normal, viable | N/A | [83] |
| Gli2−/− | Global | Down | Small lungs and fused lobes, no notochord regression, loss of pituitary, craniofacial defects | Perinatal | [83] |
|
Gli2P1−4 (S/A mutation at four PKA sites) |
Knock-in | Up | Exencephaly, partially open neural tube, extra anterior digit, enlarged facio-cranial features | Between E14.5 to birth | [5] |
| Xt (Spontaneous loss-of-function mutation in Gli3) | Global | Up | Dorsalized neural tube, reduced cortical size, absent hippocampus and choroid plexus | N/A | [88] |
| Gli3lox/lox;NestinCre | E12.5 | Up | Loss of upper layer projection neurons (PNs), defects in cortical neuron specification and positioning | N/A | [92] |
| Shh−/−;Gli3−/− | Global knockout | N/A | 91% exencephalic, relatively normal telencephalon, missing dorsal midline structure, normal pan-ventral genes such as Dlx2 Gsh2, Nkx2.1 | N/A | [52] |
| Shh−/−;Gli3+/− | Global | Down | Partial rescue of Shh-null phenotype: two discernable eyes, reduced probiscus, partial dorsal–ventral patterning rescue | N/A | [52] |
| Gli1−/−;Gli3+/− | Global | Up | Viable, polydactylyl | N/A | [83] |
| Gli1−/−;Gli2−/− | Global | Down | Decreased viability by E18.5, loss of pituitary tissue, lung lobes defects | Perinatal | [83] |
| Gli1−/−;Gli2+/− | Global | Down | Some loss of ventral spinal cord, small lungs | Perinatal | [83] |